Inventive deal structures are on the rise within China’s life sciences industry, with the “NewCo” model having garnered significant interest among Chinese pharmaceutical companies in recent years. In 2024, several landmark...more
China’s Ministry of Science and Technology (MOST) officially announced on June 1, 2023 the release of the “Detailed Implementation Rules for the Management Regulations of Human Genetic Resources” (the Detailed HGR Rules)....more
6/6/2023
/ Biotechnology ,
China ,
Compliance ,
Export Controls ,
Genetic Materials ,
Genetic Testing ,
Healthcare ,
Life Sciences ,
Multinationals ,
Pharmaceutical Industry ,
Popular